Clinical trials identified intravitreal vascular endothelial growth factor inhibitors (anti-VEGF
agents) have the potential to stabilise or even improve visual acuity outcomes in …

Background: Neovascular age-related macular degeneration (AMD) has a poor prognosis if
left untreated, frequently resulting in legal blindness. Ranibizumab is approved for treating …

Purpose: The purpose of this study was twofold: first, to prospectively compare visual acuity
(VA) scores obtained with Snellen charts versus Early Treatment Diabetic Retinopathy Study …

PURPOSE: To evaluate the integrity of the photoreceptor inner segment/outer segment
(IS/OS) junction using spectral-domain optical coherence tomography (SD OCT) in patients …

Purpose: The purpose of this study was to evaluate the predictive value of spectral domain-
optical coherence tomography-determined integrity of the photoreceptor inner …

Age-related cataracts are the leading cause of visual impairment among older adults. Many
significant cases remain undiagnosed or neglected in communities, due to limited …

Objectives To evaluate the comparative effectiveness and safety of intravitreal bevacizumab,
ranibizumab and aflibercept for patients with choroidal neovascular age-related macular …

OBJECTIVE: To describe the underlying principles used to develop a web-based algorithm
that incorporated intravitreal anti–vascular endothelial growth factor (anti-VEGF) treatment …

Background Studies on vitrectomy with and without internal limiting membrane (ILM) peeling
for idiopathic epiretinal membrane (ERM) have yielded uncertain results regarding clinical …

COVID-19 has led to massive disruptions in societal, economic and healthcare systems
globally. While COVID-19 has sparked a surge and expansion of new digital business …